Statement Of Cash Flows [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166306

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for decrease (increase) in trade and other receivables
2,068 EUR
81,000 EUR
Adjustments for increase (decrease) in trade and other payables
1,138 EUR
1,398 EUR
Adjustments for increase (decrease) in other liabilities
623,000 EUR
103,000 EUR
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
137,000 EUR
581,000 EUR
Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates
191,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issue of bonds, notes and debentures
14,994 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.